Psychiatric Drug Flashcards
How long before the antidepressants take effect?
Clinical Onset often takes up to 2 weeks
What are the types of antidepressants
- Tricyclic Antidepressants (TCA)
- Selective Serotonin ReUptake Inhibitors (SSRI)
- Atypical Agents
- Monoamine Oxidase Inhibitors
MOA of TCA
whats the common uses
samples of TCA
Mechanism of action
- Inhibit synaptic reuptake of norepinephrine and serotonin
- Variable antagonist activity at histamine, anti-muscarinic acetylcholine, α1 adrenergic, NMDA, μ1-opioid receptors, sodium channel blockade
Common medications
- Amitriptyline
- imipramine
- desipramine
- doxepin
- nortriptyline
Common uses
- Depression, chronic pain (neuropathic and fibromyalgia), some forms of acute pain
- Use decreasing due to side effects
What are the common side effects of TCA
- Postural Hypotension
- Urinary retention
- blurred vision
- dried mouth
- Hypotension - common
- QTC prolongation
- DELIRIUM - CHOLINERGIC DEFICIENCY
- SEROTONIN SYNDROME
- NARROW THERAPEUTIC INDEX
drug class that has a narrow therapeutic index
what are the changes that you can see?
TCA
Narrow therapeutic index
- Can cause EKG changes particularly with overdose; non-symptomatic EKG changes will subside with time
- Flattening/inversion of T waves, widening of QRS complex, prolongation of QT interval, bundle branch block, premature ventricular contractions, conduction abnormities, ventricular arrhythmias
Reduction of seizure threshold (dose-dependent) – Caution use with tramadol or meperidine
Serotonin syndrome
- Avoid use with MAO-I – inhibit breakdown of neurotransmitters (i.e., dopamine, serotonin, norepinephrine)
What effect will chronic TCA use have with pressors
-
Decreased response to sympathomimetics with chronic (>6 weeks) TCA use [MORE DRUG TO GET APPROPRIATE RESPONSE]
- Adrenergic receptors are sensitized, downregulation of β receptors or catecholamine stores depleted
What effect will acute TCA use have with pressors
Sympathomimetic agents
- Exaggerated response of sympathomimetics with new TCA starts – Increased amount of catecholamines present to stimulate post-synaptic receptors due to norepinephrine reuptake blockade
What effect will TCA use have with the induction of anesthesia
- Possible increased incidence of cardiac dysrhythmias (mostly with halothane)
you have a patient on TCA. which drug for N/V when given may cause excessive sedation?
Anticholinergic agents (i.e., diphenhydramine,
scopolamine)
- Additive side effects with anticholinergic drugs –> increased risk for excess sedation, postoperative delirium, confusion
Why would there be an augmented analgesic and ventilatory effects of opioids when used with TCA?
Because TCA has CYP450 inhibition
–> may increase opioids and sedatives in the system
SSRI MOA
Mechanism of action
– Major mechanism: inhibits the reuptake of serotonin
– Minor mechanisms:
- Inhibits norepinephrine reuptake
- Inhibits dopamine uptake
- Histamine, musarinic receptor antagonist
SSRI that has an active metabolite
Fluoxetine
* maybe given to a patient without parenteral access and liver dysfunction because of an active metabolite and long half-life (1-4 days)
Your patient on Fluvoxamine has been NPO for 45 hours (2ish days). what can you expect?
You may see withdrawal symptoms
* Fluvoxamine has the shortest half-life among SSRIs (15 h)
SSRI common SE
*Should not have much SEDATION
QTC prolongation
*lesser effects when it comes to sedation as compared to TCA
SSRI: FLUOXETINE
ADVERSE SE
- BRADYCARDIA
- SYNCOPAL OCCASIONAL OCCURENCE IN ELDERLY PATIENTS
What can you expect in an SSRI withdrawal?
when do you see it?
- Dizziness,GI complaints,flu-like symptoms,anxiety, insomnia, paresthesias, myalgia, visual disturbances
- Requires atleast ~1month therapy to be at risk
- More severe with shorter acting agents paroxetine,Fluvoxamine)
- Seen within 1-7days after discontinuation
- Taper before discontinuation
Serotonin Syndrome
– Avoid use with MAO-I or have an adequate washout
– Cautious use with drugs with MAO-I properties(i.e, opioids, linezolid, methylene blue)
– Have adequate washout of the drug from the system if possible
MIRTAZAPINE
POTENT ANTAGONIST OF
- Potent antagonist of 5-HT2 and 5-HT3 serotonin receptors and H1 histamine receptors
- Moderate peripheral α1 adrenergic and muscarinic antagonist
NE:SE reuptake inhibitors
SE
decrease seizure threshold